NEW YORK (360Dx) — Banyan Biomarkers announced today that it has nonexclusively licensed its proprietary blood biomarkers of traumatic brain injury (TBI) to Abbott.
NEW YORK (360Dx) — Banyan Biomarkers announced today that it has nonexclusively licensed its proprietary blood biomarkers of traumatic brain injury (TBI) to Abbott.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.